Skip to main content

Aripiprazole (International)

In the US, Aripiprazole (aripiprazole systemic) is a member of the drug class atypical antipsychotics and is used to treat Agitated State, Autism, Bipolar Disorder, Borderline Personality Disorder, Depression, Major Depressive Disorder, Obsessive Compulsive Disorder, Post Traumatic Stress Disorder, Schizoaffective Disorder, Schizophrenia and Tourette's Syndrome.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05AX12

CAS registry number (Chemical Abstracts Service)

0129722-12-9

Chemical Formula

C23-H27-Cl2-N3-O2

Molecular Weight

448

Therapeutic Category

Neuroleptic agent

Chemical Names

2(1H)-Quinolinone, 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro- (USAN)

7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril (WHO)

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs